Ubiquitome’s COVID-19 Fast Test Device in Spotlight
AUCKLAND, New Zealand--(BUSINESS WIRE)--Ubiquitome’s ability to deliver fast test results for COVID-19 is attracting global…
6 years ago
Michael Terence Publishing Announce the Release of “The Amorous Postman” by Ben Goldsmith
Michael Terence Publishing is excited to announce the release of The Amorous Postman – a…
6 years ago
IDC recognises X0PA AI as one of the top four Innovative companies in Asia-Pacific in AI-automation
SINGAPORE - Media OutReach - 27 March 2020 - Artificial Intelligence (AI) is the buzzword of the tech startup…
6 years ago
New Highlights at LED Expo Thailand + Light ASEAN 2020 to Broaden Show Horizons
ASEAN’s largest event on LED technology and lighting solutions is gearing up for its 8th…
6 years ago
Free Thai IDN .TW Domain Name Giveaways by WebNIC
WebNIC launches free Thai domain giveaway program for aspiring Thai business and website owners. Bangkok,…
6 years ago
CG Oncology Announces License and Commercialization Agreement with Kissei Pharmaceutical Co., Ltd. for CG0070 in Japan and Other Asian Countries
- Kissei Gains Regional License to CG0070 for Japan, South Korea, Taiwan and Other Asian…
6 years ago
Hinfo Guest Digital Compendium: Accessible Easily on Over 3.7 Billion Devices Worldwide, via Their Mobile App and New Website
Hinfo.com has been revamped to become the single source for everything about their guest digital…
6 years ago
Dr. Reddy’s Laboratories Issues Voluntary Nationwide Recall of Phytonadione Injectable Emulsion USP, 10 mg/mL Single-Dose Ampules Due To Ampules Breaking And Shattering Upon Opening
HYDERABAD, India & PRINCETON, N.J.--(BUSINESS WIRE)--Dr. Reddy’s Laboratories Ltd. (along with its subsidiaries together referred…
6 years ago
Autodoc donates EUR 50,000 for coronavirus research
Berlin-based company sets standards for commitment BERLIN--(BUSINESS WIRE)--Autodoc, Europe’s largest online retailer of car spare…
6 years ago
Poxel Reports Financial Results for Full Year 2019 and Provides Corporate Update
Successful completion of Imeglimin Phase 3 TIMES program in Japan for the treatment of type…
6 years ago